SHL Telemedicine Ltd. (SHLT)
USD 2.05
(0.99%)
USD 2.05
(0.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -7.05 Million USD | -9160.29% |
| 2022 | -76 Thousand USD | 99.46% |
| 2021 | -14.11 Million USD | -5175.54% |
| 2020 | 278 Thousand USD | -95.12% |
| 2019 | 5.69 Million USD | -43.84% |
| 2018 | 10.14 Million USD | 321.14% |
| 2017 | 2.4 Million USD | 121.7% |
| 2016 | -11.09 Million USD | 33.3% |
| 2015 | -16.63 Million USD | -2106.63% |
| 2014 | 829 Thousand USD | -62.86% |
| 2013 | 2.23 Million USD | 130.56% |
| 2012 | -7.3 Million USD | -282.74% |
| 2011 | 3.99 Million USD | -17.77% |
| 2010 | 4.86 Million USD | -9.6% |
| 2009 | 5.37 Million USD | 140.8% |
| 2008 | 2.23 Million USD | -90.45% |
| 2007 | 23.37 Million USD | 376.17% |
| 2006 | -8.46 Million USD | -12.14% |
| 2005 | -7.54 Million USD | -60.02% |
| 2004 | -4.71 Million USD | 53.73% |
| 2003 | -10.19 Million USD | -822.54% |
| 2002 | 1.41 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2 Million USD | 17.32% |
| 2024 Q2 | -2 Million USD | 0.0% |
| 2023 Q1 | -1.1 Million USD | -1003.52% |
| 2023 Q3 | -2.41 Million USD | -10.25% |
| 2023 Q2 | -2.19 Million USD | -97.98% |
| 2023 Q4 | -2.41 Million USD | 0.0% |
| 2023 FY | -7.03 Million USD | -9160.29% |
| 2022 Q2 | 24.89 Thousand USD | 99.18% |
| 2022 Q3 | -50.5 Thousand USD | -302.84% |
| 2022 FY | -76 Thousand USD | 99.46% |
| 2022 Q4 | -100.45 Thousand USD | -98.91% |
| 2022 Q1 | 12.5 Thousand USD | 100.65% |
| 2021 FY | -14.11 Million USD | -5175.54% |
| 2021 Q2 | -5.14 Million USD | 0.0% |
| 2021 Q1 | -5.14 Million USD | -2528.34% |
| 2021 Q3 | -1.91 Million USD | 62.77% |
| 2021 Q4 | -1.91 Million USD | 0.0% |
| 2020 Q2 | 68.37 Thousand USD | 101.11% |
| 2020 Q3 | 105 Thousand USD | 53.56% |
| 2020 FY | 278 Thousand USD | -95.12% |
| 2020 Q4 | 211.7 Thousand USD | 101.63% |
| 2020 Q1 | 34 Thousand USD | -98.03% |
| 2019 Q2 | 3.98 Million USD | 100.28% |
| 2019 Q1 | 1.98 Million USD | 41.95% |
| 2019 Q3 | 859 Thousand USD | -78.43% |
| 2019 FY | 5.69 Million USD | -43.84% |
| 2019 Q4 | 1.72 Million USD | 101.01% |
| 2018 Q4 | 1.4 Million USD | 99.27% |
| 2018 Q2 | 8.7 Million USD | 99.21% |
| 2018 Q1 | 4.36 Million USD | 2216.98% |
| 2018 FY | 10.14 Million USD | 321.14% |
| 2018 Q3 | 703 Thousand USD | -91.92% |
| 2017 Q1 | 1.01 Million USD | 127.69% |
| 2017 FY | 2.4 Million USD | 121.7% |
| 2017 Q4 | 188.5 Thousand USD | 0.0% |
| 2017 Q3 | 188.5 Thousand USD | -81.44% |
| 2017 Q2 | 1.01 Million USD | 0.0% |
| 2016 Q3 | -3.66 Million USD | -95.03% |
| 2016 Q1 | -1.88 Million USD | 76.37% |
| 2016 Q2 | -1.88 Million USD | 0.0% |
| 2016 FY | -11.09 Million USD | 33.3% |
| 2016 Q4 | -3.66 Million USD | 0.0% |
| 2015 FY | -16.63 Million USD | -2106.63% |
| 2015 Q4 | -7.95 Million USD | 0.0% |
| 2015 Q3 | -7.95 Million USD | -537.78% |
| 2015 Q2 | -1.24 Million USD | -187.39% |
| 2015 Q1 | 1.42 Million USD | 192.02% |
| 2014 FY | 829 Thousand USD | -62.86% |
| 2014 Q1 | 3000.00 USD | -99.92% |
| 2014 Q2 | 79 Thousand USD | 2533.33% |
| 2014 Q3 | 258 Thousand USD | 226.58% |
| 2014 Q4 | 489 Thousand USD | 89.53% |
| 2013 FY | 2.23 Million USD | 130.56% |
| 2013 Q4 | 3.72 Million USD | 408.53% |
| 2013 Q3 | -1.2 Million USD | -2182.76% |
| 2013 Q2 | 58 Thousand USD | 116.81% |
| 2013 Q1 | -345 Thousand USD | 91.38% |
| 2012 Q3 | -963 Thousand USD | -11.07% |
| 2012 FY | -7.3 Million USD | -282.74% |
| 2012 Q4 | -4 Million USD | -315.37% |
| 2012 Q1 | -1.47 Million USD | -536.09% |
| 2012 Q2 | -867 Thousand USD | 41.18% |
| 2011 FY | 3.99 Million USD | -17.77% |
| 2011 Q4 | 338 Thousand USD | -76.66% |
| 2011 Q3 | 1.44 Million USD | 24.29% |
| 2011 Q1 | 1.04 Million USD | 6.84% |
| 2011 Q2 | 1.16 Million USD | 11.38% |
| 2010 Q1 | 1.59 Million USD | 14.69% |
| 2010 Q4 | 979 Thousand USD | 20.12% |
| 2010 Q3 | 815 Thousand USD | -44.71% |
| 2010 FY | 4.86 Million USD | -9.6% |
| 2010 Q2 | 1.47 Million USD | -7.47% |
| 2009 Q4 | 1.38 Million USD | 13.67% |
| 2009 FY | 5.37 Million USD | 140.8% |
| 2009 Q3 | 1.22 Million USD | -21.31% |
| 2009 Q2 | 1.55 Million USD | 28.03% |
| 2009 Q1 | 1.21 Million USD | 0.0% |
| 2008 Q2 | 3.96 Million USD | 0.0% |
| 2008 FY | 2.23 Million USD | -90.45% |
| 2007 FY | 23.37 Million USD | 376.17% |
| 2006 FY | -8.46 Million USD | -12.14% |
| 2005 FY | -7.54 Million USD | -60.02% |
| 2004 FY | -4.71 Million USD | 53.73% |
| 2003 FY | -10.19 Million USD | -822.54% |
| 2002 FY | 1.41 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CareCloud, Inc. | -48.67 Million USD | 85.504% |
| Augmedix, Inc. | -19.17 Million USD | 63.194% |
| BrightSpring Health Services, Inc. Common Stock | -154.6 Million USD | 95.436% |
| CareCloud, Inc. | -48.67 Million USD | 85.504% |
| HealthEquity, Inc. | 55.71 Million USD | 112.665% |
| iCoreConnect Inc. | -15.55 Million USD | 54.629% |
| Inovalon Holdings, Inc. | 22.57 Million USD | 131.25% |
| Nutex Health, Inc. | -45.78 Million USD | 84.589% |
| Omnicell, Inc. | -20.37 Million USD | 65.363% |
| OneMedNet Corporation | -23.2 Million USD | 69.593% |
| Progyny, Inc. | 62.03 Million USD | 111.374% |
| Renalytix Plc | -33.45 Million USD | 78.91% |
| Schrödinger, Inc. | 40.72 Million USD | 117.328% |
| Simulations Plus, Inc. | 9.95 Million USD | 170.886% |
| SOPHiA GENETICS SA | -78.98 Million USD | 91.066% |
| Streamline Health Solutions, Inc. | -18.69 Million USD | 62.261% |
| Ontrak, Inc. | -27.92 Million USD | 74.728% |
| GE HealthCare Technologies Inc. | 1.56 Billion USD | 100.45% |
| Sharecare, Inc. | -128.49 Million USD | 94.509% |
| Aclarion, Inc. | -4.91 Million USD | -43.667% |
| CareMax, Inc. | -683.34 Million USD | 98.967% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.35 Million USD | -31.743% |
| Forian Inc. | 11.1 Million USD | 163.529% |
| Bullfrog AI Holdings, Inc. Warrants | -5.35 Million USD | -31.743% |
| HeartBeam, Inc. | -14.63 Million USD | 51.8% |
| GeneDx Holdings Corp. | -175.76 Million USD | 95.986% |
| SCWorx Corp. | -3.98 Million USD | -77.235% |
| Minerva Surgical, Inc. | -34.11 Million USD | 79.315% |
| Definitive Healthcare Corp. | -202.38 Million USD | 96.514% |
| 10x Genomics, Inc. | -255.09 Million USD | 97.234% |
| Zhongchao Inc. | -11.33 Million USD | 37.755% |
| Accolade, Inc. | -99.8 Million USD | 92.93% |
| MSP Recovery, Inc. | -56.34 Million USD | 87.478% |
| R1 RCM Inc. | 3.3 Million USD | 313.818% |
| Spok Holdings, Inc. | 15.66 Million USD | 145.04% |
| Privia Health Group, Inc. | 23.07 Million USD | 130.573% |
| EUDA Health Holdings Limited | -10.03 Million USD | 29.717% |
| TruBridge, Inc. | -45.78 Million USD | 84.59% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | -154.6 Million USD | 95.436% |
| Sharecare, Inc. | -128.49 Million USD | 94.509% |
| Health Catalyst, Inc. | -118.14 Million USD | 94.028% |
| GoodRx Holdings, Inc. | -8.86 Million USD | 20.433% |
| Premier, Inc. | 119.54 Million USD | 105.902% |
| HealthStream, Inc. | 15.21 Million USD | 146.381% |
| Certara, Inc. | -55.35 Million USD | 87.254% |
| GeneDx Holdings Corp. | -175.76 Million USD | 95.986% |
| Ontrak, Inc. | -27.92 Million USD | 74.728% |
| CareCloud, Inc. | -48.67 Million USD | 85.504% |
| EUDA Health Holdings Limited | -10.03 Million USD | 29.717% |
| HeartBeam, Inc. | -14.63 Million USD | 51.8% |
| Mangoceuticals, Inc. | -9.21 Million USD | 23.408% |
| CareMax, Inc. | -683.34 Million USD | 98.967% |
| Healthcare Triangle, Inc. | -12.33 Million USD | 42.815% |
| National Research Corporation | 30.97 Million USD | 122.783% |
| Aclarion, Inc. | -4.91 Million USD | -43.667% |
| OptimizeRx Corporation | -17.56 Million USD | 59.831% |